Within today’s modern infusion pump market, a variety of challenges - including patient safety and cybersecurity concerns - continue to require a vigilant focus from pump manufacturers. See why now is the time for these manufacturers to step up.
Innovations in the safety and usability of IV infusion pumps have made great advances in today’s ever-changing technological landscape. But a variety of challenges, including cybersecurity concerns, continue to require a vigilant focus from pump manufacturers.
In this white paper, learn more about:
How pump safety and usability resulted in recalls with implications for patients and hospitals
An increased focus on cybersecurity vulnerabilities, which can pose significant operational and patient safety challenges
A multiyear analysis of pump problem reporting in the FDA MAUDE database revealing increased frequency of reports for certain pump manufacturers, except for B. Braun
How the FDA has recognized cybersecurity risk mitigation standards for infusion pump manufacturers (UL 2900 series) to address vulnerabilities, malware and software weaknesses
How B. Braun pumps—with zero FDA Class I recalls for the past decade*—are designed to enhance patient safety and operational efficiencies
Offered Free by: B. Braun See All Resources from: B. Braun